The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

bioRxiv (Cold Spring Harbor Laboratory)

January 31, 2020

10.1101/2020.01.31.929042

Cited by 757

Related Papers

No related papers found

Powered by citation graph analysis